U.S. markets open in 4 hours 46 minutes

CASI Pharmaceuticals, Inc. (CASI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.52000.0000 (0.00%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close1.5200
Open1.5400
Bid0.0000 x 3200
Ask1.7600 x 800
Day's Range1.5152 - 1.5600
52 Week Range1.1500 - 3.6700
Volume95,419
Avg. Volume498,015
Market Cap188.395M
Beta (5Y Monthly)0.75
PE Ratio (TTM)N/A
EPS (TTM)-0.4030
Earnings DateNov 10, 2020 - Nov 16, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.20
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • CASI Pharmaceuticals, Inc. to Participate in Two Upcoming September Conferences
    PR Newswire

    CASI Pharmaceuticals, Inc. to Participate in Two Upcoming September Conferences

    CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced that Dr. Wei-Wu He, Chairman and Chief Executive Officer of CASI Pharmaceuticals, will be presenting at the following upcoming virtual conferences in September. Details for the virtual conferences are as follows.

  • The CASI Pharmaceuticals (NASDAQ:CASI) Share Price Is Up 53% And Shareholders Are Holding On
    Simply Wall St.

    The CASI Pharmaceuticals (NASDAQ:CASI) Share Price Is Up 53% And Shareholders Are Holding On

    Some CASI Pharmaceuticals, Inc. (NASDAQ:CASI) shareholders are probably rather concerned to see the share price fall...

  • Zacks Small Cap Research

    CASI: A Change in Strategy

    By Beth Senko, CFA NASDAQ:CASI READ THE FULL CASI RESEARCH REPORT CASI Pharmaceuticals (NASDAQ:CASI) signaled a shift in its business strategy in March – focusing its efforts on its hematology franchise and deemphasizing its ANDA portfolio. This change scales back CASI’s initial broad-reaching goal to be the leading provider of high quality proprietary, licensed and ANDA pharmaceuticals to the